Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 2Thoracic 1Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Breast 1

Conditions

Precancerous Conditions 5Neoplasms, Plasma Cell 5Multiple Myeloma 5Lymphoma 5Leukemia 5Anemia 5Lymphoproliferative Disorders 4Waldenstrom Macroglobulinemia 3Sezary Syndrome 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Mycosis Fungoides 3Monoclonal Gammopathy of Undetermined Significance 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Leukemia, Prolymphocytic 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia, Large Granular Lymphocytic 3Immunoglobulin Light-chain Amyloidosis 3Immunoblastic Lymphadenopathy 3Hodgkin Disease 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Hairy Cell 2Burkitt Lymphoma 2Myeloproliferative Disorders 1

Interventions

sargramostim 1Epoetin Alfa 1Cyclophosphamide 1Carboplatin 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Drug-Related Side Effects and Adverse Reactions × Epoetin Alfa × Other neoplasm × Clear all
NCT00003600 2016-07-13

Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy

Alliance for Clinical Trials in Oncology

Phase 3 Completed
344 enrolled
BreastClassical hematologyLymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cellThoracic

Anemia, Breast Neoplasms, Leukemia, Lung Neoplasms, Lymphoma, Multiple Myeloma, Myeloproliferative Disorders, Precancerous Conditions, Neoplasms, Plasma Cell, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡